The influence of age on the GH-IGF1 axis in patients with acromegaly

European Journal of Endocrinology

Volumn 159, Issue 4, 2008, Pages 375-379

  Tanimoto, Keiji ^a,b   Hizuka, Naomi ^a   Fukuda, Izumi ^a   Takano, Kazue ^a   Hanafusa, Toshiaki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ACROMEGALY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLON POLYP; COLONOSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE INTOLERANCE; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; HYPOPHYSIS TUMOR; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME; ADOLESCENT; AGING; BLOOD; BODY COMPOSITION; METABOLISM; MIDDLE AGED; PREVALENCE; SECRETION; SEX RATIO;

ACROMEGALY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; BODY COMPOSITION; COLONIC POLYPS; DISEASE PROGRESSION; FEMALE; GLUCOSE INTOLERANCE; HUMAN GROWTH HORMONE; HUMANS; HYPERLIPIDEMIAS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 54049123236     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0243     Document Type: Article

References (19)

1. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734.
2. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617.
3. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674.
4. Kauppinen-Mäkelin R, Sane T, Reunanen A, Välmäki MJ, Niskanen L, Markkanen H, Löyttyniemi E, Ebeling T, Jaatinen F, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J & Voutilainen E. A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4081-4086.
5. Terzolo M, Tappero G, Borretta G, Asnaghi G, Pia A, Reimondo G, Boccuzzi A, Cesario F, Rovero E, Paccotti P & Angeli A. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age. Archives of Internal Medicine 1994 154 1272-1276.
6. Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A & Delwaide J. The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. Journal of Clinical Endocrinology and Metabolism 1995 80 3223-3226.
7. Tanaka T, Tachibana K, Shimatsu A, Katsumata N, Tsushima T, Hizuka N, Fujieda K, Yokoya S & Irie M. A nationwide attempt to standardize growth hormone assays. Hormone Research 2005 64 6-11.
8. Shimatsu A, Fujieda K, Hanyu K, Tanaka T, Yokoya S, Miyaji Y, Hizuka N, Hasegawa Y, Tachibana K, Ohyama K, Seino Y, Kato Y, Nishi Y, Kono H & Irie M. Clinical evaluation of serum IGF-1 IGF-II and IGFBP-3 measured by IRMA kits in adulthood. Horumon to Rinsho 1996 44 1129-1138 (in Japanese).
9. Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F & Ghigo E. The IGF-I response to very low rhGH doses is preserved in human ageing. Clinical Endocrinology 1998 49 757-763.
10. Lissett CA & Shalet SM. The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing. Clinical Endocrinology 2003 58 238-245.
11. Clayton P, Gleeson H, Monson J, Popovic V, Shalet SM & Christiansen S. Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Hormone and IGF Research 2007 17 369-382.
12. Sathiavageeswaran M, Burman P, Lawrence D, Harris AG, Falleti MG, Maruff P & Wass J. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. European Journal of Endocrinology 2007 156 439-447.
13. Leung K-C, Johannsson G, Leong GM & Ho KKY. Estrogen regulation of growth hormone action. Endocrine Reviews 2004 25 693-721.
14. Lundin P, Engström BE, Karlsson FA & Burman P. Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR. American Journal of Neuroradiology 1997 18 765-772.
15. Colao A, Pivonello R, Auriemma RS, Briganti F, Galdiero M, Tortora F, Caranci F, Cirillo S & Lombardi G. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. Journal of Clinical Endocrinology and Metabolism 2006 91 2112-2118.
16. Lloyd RV, Kovacs K, Young WF Jr, Farrell WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW & Horvath E. Pathology and genetics of tumours of endocrine organs: tumour of the pituitary gland. In World Health Organization Classification of Tumours, pp 10-47. Eds RA DeLellis, RV Lloyd, PU Heitz & C Eng, Lyon: IARC Press, 2004.
17. Sanno N, Teramoto A, Osamura RY, Horvath E, Kovacs K, Lloyd RV & Scheithauer BW. Pathology of pituitary tumors. Neurosurgery Clinics of North America 2003 14 25-39.
18. Ministry of Health, Labour and Welfare. National Diabetes Survey, 2002 (in Japanese).
19. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey in Japan, 2006 (in Japanese).